Berkeley HeartLab provides cardiovascular disease (CVD) management tools and services with a unique focus on the secondary prevention market. Through our combination of proprietary lipid testing technology, esoteric testing capability, advanced therapy guidelines, sophisticated informatic tools, and patient support services, we are providing physicians and patients a viable disease management offering for CVD.
Unlike other lipid testing companies that are focused on the primary screening market for CVD, our proprietary testing technology allows for the characterization of risk in a patient and uniquely allows for ongoing therapeutic monitoring of a patientís disease. Our tests routinely receive private insurance and Medicare reimbursement.
Berkeley HeartLab provides a complete menu of tests to characterize a patient's Cardiovascular Disease Risk, to personalize therapy, and to monitor treatment.
Click here to view the tests that Berkeley HeartLab provides.
For more information about Berkeley HeartLab, visit www.bhlinc.com